A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Clinical trial NCT03740529 · COMPLETED

Trial details

NCT number: NCT03740529
Sponsor: Loxo Oncology, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Waldenstrom Macroglobulinemia Mantle Cell Lymphoma Marginal Zone Lymphoma B-cell Lymphoma Small Lymphocytic Lymphoma

Start date: 2019-03-15
Primary completion: 2025-01-27
Enrollment: 803

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.